CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Principal Accounting Officer sold 250 shares at $39.93 ($9,983)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,878 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 3,583 shares at $50.01 ($179,200)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,927 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 2,529 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,599 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 3,673 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,027 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,368 shares (to pay taxes)
- 4 Open-market sale Principal Accounting Officer sold 345 shares at $47.30 ($16,319)
- 4 Gift Director gave 4,315 shares (gift)
- 4 Open-market sale Principal Accounting Officer sold 472 shares at $47.12 ($22,241)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,056 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,596 shares (to pay taxes)
Page 16 of 38 · 758 filings